SCHEMBL4120274

SCHEMBL4120274

Fc1ccc(SCl)cc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
HTT P42858 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SLC2A1 P11166 1/20 0.36
ITGB3 P05106 1/20 0.35
ITGAV P06756 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
TYMS P04818 1/20 0.35
KAT2B Q92831 2/20 0.34
PIN1 Q13526 1/20 0.34
NISCH Q9Y2I1 1/20 0.34
TSHR P16473 1/20 0.34
PLA2G1B P04054 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18680750 0.81 RAPGEF4 (0.35) MEN1KMT2AALDH1A1MAPTRAPGEF4
SCHEMBL4126762 0.80 DDB1 (0.37) ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL24804422 0.79 MEN1 (0.38) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL642701 0.79 KMT2A (0.40) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL5013607 0.77 AHR (0.46) MEN1KMT2AALDH1A1MAPTTSHR
SCHEMBL16555940 0.76 ALDH1A1 (0.43) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL20384243 0.74 AR (0.40) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL2652648 0.74 TSHR (0.41) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL30596387 0.71 ALDH1A1 (0.43) MEN1KMT2AHTTALDH1A1MAPT
SCHEMBL26111322 0.71 ALDH1A1 (0.43) MEN1KMT2AHTTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090192190-A1 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR ASTRAZENECA AB (SE) 2009-07-30 US disclosed
EP-1890993-A2 BENZOIC ACID DERIVATIVES THAT ARE MODULATORS OR ANTAGONISTS OF GLYR AstraZeneca AB (SE) 2008-02-27 EP disclosed
WO-2006121390-A2 BENZOIC ACID DERIVATIVES THAT ARE MODULATORS OR AGONISTS OF GLYR ASTRAZENECA AB (SE) 2006-11-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192190-A1 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR GLRA1, GLRB, GPBAR1 MEN1 2512/4885KMT2A 2465/4885HTT 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.